Cohance Lifesciences Limited
COHANCE
Kedudukan dalam Saham
#6330
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Harga Saham
$5.08
Modal Pasaran
$1.94B
Perubahan (1 hari)
0.56%
Perubahan (1 tahun)
-57.14%
Negara
IN
Perdagangan Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Nisbah P/S bagi Cohance Lifesciences Limited (COHANCE)
Nisbah P/S pada October 2026 TTM: 75.08
Menurut laporan kewangan dan harga saham terkini Cohance Lifesciences Limited, nisbah P/S semasa (TTM) ialah 75.08. Pada akhir 2024, nisbah P/S syarikat ialah 16.21.
Sejarah nisbah P/S untuk Cohance Lifesciences Limited dari 2019 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 75.08 | 232.64% |
| 2025 | 22.57 | 39.25% |
| 2024 | 16.21 | 80.67% |
| 2023 | 8.97 | -26.49% |
| 2022 | 12.21 | -5.42% |
| 2021 | 12.91 | 306.97% |
| 2020 | 3.17 | -72.93% |
| 2019 | 11.71 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -90.60% |
IN
|
